X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare WYETH LTD with Novartis - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs NOVARTIS - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

NOVARTIS 
   Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD NOVARTIS WYETH LTD/
NOVARTIS
 
P/E (TTM) x 27.7 295.9 9.4% View Chart
P/BV x 5.3 25.2 21.2% View Chart
Dividend Yield % 1.3 1.4 88.0%  

Financials

 WYETH LTD   NOVARTIS
EQUITY SHARE DATA
    WYETH LTD
Mar-13
NOVARTIS
Mar-17
WYETH LTD/
NOVARTIS
5-Yr Chart
Click to enlarge
High Rs1,044855 122.2%   
Low Rs818666 122.9%   
Sales per share (Unadj.) Rs298.6219.0 136.3%  
Earnings per share (Unadj.) Rs57.219.1 299.7%  
Cash flow per share (Unadj.) Rs58.420.3 287.8%  
Dividends per share (Unadj.) Rs17.0010.00 170.0%  
Dividend yield (eoy) %1.81.3 138.8%  
Book value per share (Unadj.) Rs249.5307.0 81.3%  
Shares outstanding (eoy) m22.7229.96 75.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.13.5 89.9%   
Avg P/E ratio x16.339.8 40.9%  
P/CF ratio (eoy) x15.937.5 42.6%  
Price / Book Value ratio x3.72.5 150.7%  
Dividend payout %29.752.4 56.7%   
Avg Mkt Cap Rs m21,15722,779 92.9%   
No. of employees `0000.50.7 73.0%   
Total wages/salary Rs m4001,393 28.7%   
Avg. sales/employee Rs Th13,787.49,736.2 141.6%   
Avg. wages/employee Rs Th813.02,066.8 39.3%   
Avg. net profit/employee Rs Th2,643.3849.0 311.4%   
INCOME DATA
Net Sales Rs m6,7836,562 103.4%  
Other income Rs m353702 50.3%   
Total revenues Rs m7,1367,264 98.2%   
Gross profit Rs m1,617259 624.7%  
Depreciation Rs m2736 74.1%   
Interest Rs m67 76.4%   
Profit before tax Rs m1,938917 211.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m632345 183.2%   
Profit after tax Rs m1,301572 227.3%  
Gross profit margin %23.83.9 604.3%  
Effective tax rate %32.637.6 86.7%   
Net profit margin %19.28.7 219.9%  
BALANCE SHEET DATA
Current assets Rs m6,9849,731 71.8%   
Current liabilities Rs m2,0561,830 112.3%   
Net working cap to sales %72.6120.4 60.3%  
Current ratio x3.45.3 63.9%  
Inventory Days Days9949 203.9%  
Debtors Days Days2425 95.2%  
Net fixed assets Rs m24457 427.1%   
Share capital Rs m227141 161.5%   
"Free" reserves Rs m5,4419,056 60.1%   
Net worth Rs m5,6689,196 61.6%   
Long term debt Rs m250-   
Total assets Rs m7,90111,499 68.7%  
Interest coverage x353.3128.4 275.2%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.6 150.4%   
Return on assets %16.55.0 328.1%  
Return on equity %22.96.2 368.8%  
Return on capital %34.010.1 338.7%  
Exports to sales %0.20-   
Imports to sales %36.30-   
Exports (fob) Rs m15NA-   
Imports (cif) Rs m2,465NA-   
Fx inflow Rs m15129 11.8%   
Fx outflow Rs m2,6771,734 154.4%   
Net fx Rs m-2,662-1,605 165.9%   
CASH FLOW
From Operations Rs m923-380 -243.3%  
From Investments Rs m3174,208 7.5%  
From Financial Activity Rs m-481-3,318 14.5%  
Net Cashflow Rs m759510 148.8%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.1 75.0 68.1%  
Indian inst/Mut Fund % 11.3 2.0 565.0%  
FIIs % 7.2 1.6 450.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 21.5 141.4%  
Shareholders   21,978 41,647 52.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   AJANTA PHARMA  GLENMARK PHARMA  AUROBINDO PHARMA  STRIDES SHASUN LTD  FDC LTD.  

Compare WYETH LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day up 260 Points; Pharma Stocks Top Gainers(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD 8-QTR ANALYSIS

COMPARE WYETH LTD WITH

MARKET STATS